SA Transcripts 162.79K Followers
Q3: 2026-11-02 Earnings Summary
InsightsTranscript Insights EPS of $4.76 misses by $0.02
| Revenue of $3.44B (11.85% Y/Y) beats by $5.82M
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2026 Earnings Call November 2, 2026 4:30 PM EST
Company Participants
Susie Lisa - Senior Vice President of Investor Relations
Reshma Kewalramani - CEO, President & Director
Duncan J. McKechnie - Executive VP & Chief Commercial Officer
Charles Wagner - Executive VP, COO & CFO
Conference Call Participants
Cory Kasimov - Evercore ISI Institutional Equities, Research Division
Jessica Fye - JPMorgan Chase & Co, Research Division
Salveen Richter - Goldman Sachs Group, Inc., Research Division
Geoffrey Meacham - Citigroup Inc., Research Division
Evan Seigerman - BMO Capital Markets Equity Research
Brian Abrahams - RBC Capital Markets, Research Division
Michael Yee - UBS Investment Bank, Research Division
Tazeen Ahmad - BofA Securities, Research Division
Akash Tewari - Jefferies LLC,…